Study Results Lead to New Type of Anticancer Agent (IMAGE)
Caption
The g-tubulin-specific inhibitor gatastatin (right)was developed by the research group from Glaziovianin A (AG1, left).
Credit
University of Tsukuba
Usage Restrictions
This image may be used with appropriate caption and credit.
License
Licensed content